VQ 101
Alternative Names: VQ-101Latest Information Update: 14 Oct 2024
At a glance
- Originator Vanqua Bio
- Class Antiparkinsonians; Small molecules
- Mechanism of Action Glucosylceramidase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Parkinson's disease